RAK Hospital Provides New Treatment for COVID-19 Patients
- Publish date: Thursday، 25 February 2021
- Related articles
- RAK Hospital: Fatigue and Brain Fog Among Covid-19 Long-Term Symptoms
- Unified Medical Records System to Come Into Effect in UAE in 2023
- What is Sotrovimab? The New COVID-19 Treatment
RAK Hospital is providing a new treatment option for COVID-19 patients to help reduce severe symptoms.
The hospital is offering Bamlanivimab, which is used to prevent people from falling extremely ill.
فيديو ذات صلة
This browser does not support the video element.
The medication is given as a one-time intravenous infusion in the patients arm for about an hour and consists of antibodies similar to the antibodies of patients who recovered from the disease, thereby allowing an immediate response to the virus and avoiding severe disease.
Advanced treatment for COVID-19 at RAK Hospital.
— RAK Hospital (@RAKHospital) February 24, 2021
We present as a first in the UAE - Bamlanivimab (Monoclonal Antibody produced by Eli Lilly from the US)
For further details or click https://t.co/HBSD16W7fk#Bamlanivimab #Antibody #WeAreLilly #covi̇d19 #staysafe #AHCG #covid pic.twitter.com/xqqpVkdJvq
Patients are then observed for an hour after taking the drug.
Read: UAE's Highest Restaurant to Close Temporarily
Pregnant women as well as those with low blood oxygen levels or with a high breathing or heart rate cannot be given the medication.
Image Source: Instagram